Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Building a Substitute Pancreas for Diabetics

June 27, 2010 8:38 pm | by Massachusetts Institute of Technology | News | Comments

A startup hopes implanted insulin-producing cells will free diabetics from insulin injections.

TOPICS:

Statins associated with lower cancer recurrence following prostatectomy

June 27, 2010 8:34 pm | by EurekAlert | News | Comments

(Duke University Medical Center) Men who use statins to lower their cholesterol are 30 percent less likely to see their prostate cancer come back after surgery compared to men who do not use the drugs, according to researchers at Duke University Medical Center. Researchers also...

TOPICS:

Why mercury is more dangerous in oceans

June 27, 2010 11:37 am | by EurekAlert | News | Comments

(Duke University) Even though freshwater concentrations of mercury are far greater than those found in seawater, it's the saltwater fish like tuna, mackerel and shark that end up posing a more serious health threat to humans who eat them.

TOPICS:
Advertisement

Gestational diabetes linked to serotonin and dietary protein

June 27, 2010 11:37 am | by EurekAlert | News | Comments

(University of California - San Francisco) The cause of diabetes during pregnancy is directly controlled by serotonin, a chemical produced by the body and normally known as a neurotransmitter, and is influenced by the amount of protein in the mother's diet early in pregnancy,...

TOPICS:

Carbon nanotubes form ultrasensitive biosensor to detect proteins

June 27, 2010 11:34 am | by EurekAlert | News | Comments

(Boston College) Boston College researchers have used carbon nanotubes and molecular imprinting to develop a biosensor capable of detecting proteins, according to a report in the journal Nature Nanotechnology.

TOPICS:

TGen-led studies identify genetic links to kidney disease, kidney failure

June 26, 2010 9:38 am | by EurekAlert | News | Comments

(The Translational Genomics Research Institute) Researchers at the Translational Genomics Research Institute will make two presentations at this week's 70th Scientific Sessions of the American Diabetes Association, June 25-29, in Orlando, Fla.

TOPICS:

New Data Demonstrated Efficacy and Safety of Initial Combination Therapy with Welchol(R) (colesevelam HCl) and Metformin in Drug-Naive Adult Type 2 Diabetes Patients

June 26, 2010 9:37 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J. , June 26 /- Results of a new study demonstrated that initial combination therapy with Welchol® (colesevelam HCl) 3.75 g/d and metformin (initiated at 850 mg/d; uptitrated to 1700 mg/d thereafter) significantly improved glycemic and lipid control in drug-naive adult...

TOPICS:

Improvement in Beta-Cell Function Observed After Three Years of BYETTA(R) Therapy: Data Presented at ADA 2010

June 26, 2010 9:36 am | by Bio-Medicine.Org | News | Comments

ORLANDO, Fla. , June 26, 2010 /- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) and Eli Lilly and Company (NYSE: LLY ) today announced results from a study comparing the effect of long-term treatment with either BYETTA® (exenatide) injection or Lantus® (insulin glargine) on...

TOPICS:
Advertisement

New Data Demonstrates Victoza® (liraglutide rDNA injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at 52...

June 26, 2010 9:36 am | by Bio-Medicine.Org | News | Comments

ORLANDO, Fla. , June 26 /- Poster 16LB -- Late-breaking Novo Nordisk (NVO) extension data presented today at the 70th Annual Scientific Sessions of the American Diabetes Association (ADA) showed that once-daily Victoza® in combination with metformin produced sustained and...

TOPICS:

Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes

June 26, 2010 9:36 am | by Bio-Medicine.Org | News | Comments

ORLANDO, Fla. , June 26 /- Data from four pivotal Phase III clinical trials demonstrate that linagliptin achieved statistically significant and sustained reductions in blood sugar as measured by hemoglobin A1c (HbA1c),(1-4) fasting plasma glucose (FPG)(1-4) and postprandial glucose...

TOPICS:

Information-Motivation-Behavioral Skills Analysis Advances Understanding of Barriers to Self-Monitoring of Blood Glucose

June 26, 2010 9:36 am | by Bio-Medicine.Org | News | Comments

ORLANDO, Fla. , June 26 /- An estimated 75 percent of adults with type 1 and type 2 diabetes say they believe they know what their blood sugar levels are without testing, according to data presented at the American Diabetes Association (ADA) 70th Scientific Sessions. These results are...

TOPICS:

BYDUREON(TM) Safety and Tolerability Pooled Summary Data Presented at ADA 2010

June 26, 2010 6:35 am | by Bio-Medicine.Org | News | Comments

ORLANDO, Fla. , June 26, 2010 /- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ), Eli Lilly and Company (NYSE: LLY ) and Alkermes, Inc. (Nasdaq: ALKS ) today announced results of an analysis of pooled safety data from three completed randomized controlled trials that showed the...

TOPICS:

Futures in Biotech 62: X-Ray Crystallography

June 25, 2010 9:36 pm | Podcasts | Comments

Hosts: Marc Pelletier and George W. Farr, Ph.D., vice president of biochemistry and biophysics at Aeromics and adjunct professor of physiology and biophysics at Case Western Reserve University "Blended Rabbits, Bearded Crystals, and Protein Crystallography." Dr. Alexander McPherson...

'Lucy' Predecessor Turns Back The Clock On Walking

June 25, 2010 4:42 pm | Podcasts | Comments

Anthropologist Yohannes Haile-Selassie talks about a recently unearthed Australopithecus afarensis skeleton nicknamed "Kadanuumuu." He says the individual predates "Lucy" by about 400,000 years, and that the bones suggest upright walking originated earlier than previously thought.

Building Living, Breathing Lungs In The Lab

June 25, 2010 4:42 pm | Podcasts | Comments

Laura Niklason engineered working lungs in the lab by stripping the cells from rat lungs and repopulating the remaining structure with fresh cells. Don Ingber created a "lung on a chip," which mimics the chemistry and mechanics of a working lung and could be used for drug testing.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading